Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
7.75
0.00 (0.00%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Spruce Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 17 | 119 | 26 | 105 | 564 | |
| Market Cap Growth | -77.52% | -85.46% | 361.35% | -75.29% | -81.46% | - | |
| Enterprise Value | -10 | -39 | 16 | -58 | 19 | 614 | |
| Last Close Price | 7.75 | 31.50 | 219.75 | 82.31 | 334.50 | 1823.25 | |
| PS Ratio | 3.40 | 3.53 | 11.82 | - | - | - | |
| PB Ratio | 0.33 | 0.60 | 1.56 | 0.38 | 0.94 | 3.78 | |
| P/TBV Ratio | 0.33 | 0.60 | 1.56 | 0.38 | 0.94 | 3.78 | |
| EV/Sales Ratio | - | - | 1.62 | - | - | - | |
| Debt / Equity Ratio | 0.14 | 0.10 | 0.06 | 0.09 | 0.06 | 0.04 | |
| Asset Turnover | 0.03 | 0.07 | 0.11 | - | - | - | |
| Quick Ratio | 2.03 | 2.54 | 3.94 | 6.35 | 10.03 | 16.10 | |
| Current Ratio | 2.60 | 2.90 | 4.18 | 6.72 | 10.36 | 16.43 | |
| Return on Equity (ROE) | -133.62% | -100.70% | -66.10% | -51.35% | -32.43% | -40.30% | |
| Return on Assets (ROA) | -65.06% | -47.06% | -34.28% | -27.86% | -18.17% | -21.94% | |
| Return on Capital (ROIC) | -81.34% | -62.28% | -41.68% | -30.67% | -19.21% | -23.36% | |
| Earnings Yield | -1107.76% | -305.73% | -40.17% | -178.61% | -40.41% | -5.23% | |
| FCF Yield | -1179.19% | -322.61% | -27.90% | -161.25% | -34.37% | -4.89% | |
| Buyback Yield / Dilution | -4.46% | -7.15% | -63.68% | -0.71% | -289.93% | -683.78% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.